NCT01813630View on ClinicalTrials.gov

A Clinical Study to Assess the Efficacy and Safety of DA-3002

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Turner's Syndrome
Interventions
DRUG

DA-3002

DRUG

Genotropin®

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT01813630 - A Clinical Study to Assess the Efficacy and Safety of DA-3002 | Biotech Hunter | Biotech Hunter